Clinical Trial Update: A Study of BL-M07D1 in Patients With HER2-mutated, Locally Advanced or Metastatic Non-small-cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

This update describes an ongoing Phase 1/2 study of BL-M07D1 in patients with HER2-mutated, locally advanced or metastatic non-small-cell lung cancer, with recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BL-M07D1

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: RECRUITING